Somatic mutations drive vascular aging and muscle weakness over time
Two new studies from Karolinska Institutet in Sweden have investigated how mutations that occur in muscles and blood…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…